Mariner LLC Sells 1,271 Shares of STERIS plc (NYSE:STE)

Mariner LLC lessened its holdings in STERIS plc (NYSE:STE - Free Report) by 10.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,536 shares of the medical equipment provider's stock after selling 1,271 shares during the period. Mariner LLC's holdings in STERIS were worth $2,166,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in STE. Magnolia Capital Advisors LLC raised its stake in STERIS by 1.9% in the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider's stock valued at $521,000 after purchasing an additional 48 shares in the last quarter. SkyView Investment Advisors LLC raised its position in shares of STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock valued at $765,000 after buying an additional 51 shares in the last quarter. Park Edge Advisors LLC lifted its holdings in shares of STERIS by 1.1% during the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider's stock worth $958,000 after acquiring an additional 51 shares during the last quarter. Citizens Financial Group Inc. RI grew its position in STERIS by 5.9% in the fourth quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock worth $201,000 after acquiring an additional 54 shares in the last quarter. Finally, Opal Wealth Advisors LLC increased its stake in STERIS by 5.7% in the fourth quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider's stock valued at $230,000 after acquiring an additional 60 shares during the last quarter. Institutional investors own 94.69% of the company's stock.

Wall Street Analyst Weigh In

STE has been the subject of several research analyst reports. Stephens reaffirmed an "overweight" rating and set a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. JMP Securities restated a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, April 10th. Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a report on Monday, April 7th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, STERIS presently has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Trading Down 0.6 %

NYSE:STE traded down $1.35 during midday trading on Friday, reaching $225.00. 368,819 shares of the stock traded hands, compared to its average volume of 526,071. The stock has a market capitalization of $22.11 billion, a P/E ratio of 47.77 and a beta of 0.87. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The company has a fifty day moving average of $222.89 and a 200 day moving average of $218.90. STERIS plc has a 12 month low of $200.98 and a 12 month high of $248.24.

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is currently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.